Virologist Robert Davey will screen thousands of drugs for effectiveness against COVID-19 infection
Scientists at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL), led by microbiologist Robert Davey, this week started suiting up to conduct research on live samples of the novel coronavirus, the first team in Boston to start such work on the global pandemic.
They expect to test thousands of different drugs for their ability to curb COVID-19 infection—all within a matter of weeks.